TLBiotechnology Blog

On April 2-3, 2024, the 5th CGT Asia 2024 Cell and Gene Therapy Innovation Summit took place in Shanghai, featuring the “CGT Awards 2024 2nd Asia-Pacific Cell and Gene Therapy Industry Star” award ceremony. T&L Biotech, recognized for its exemplary c..

We are pleased to announce that after obtaining DMF registration for CD3 monoclonal antibody and CD3/CD28 sorting activated magnetic beads, T&L's GMP grade products, recombinant human IL-7 protein (Cat. No. GMP-TL506) and recombinant human IL-15 prot..

Summary of protein factors involved in hematopoietic stem cell culturesource：T&L Biotechnology Release time：2023-07-13IntroductionIn recent years, stem cells have become increasingly widely used in clinical applications. However, the proportion and q..

Recently, T&L Biotechnology Ltd. (referred to as "T&L") successfully obtained the US FDA DMF registration for its CGT core raw material CD28 monoclonal antibody, with DMF registration number 038820.Your cell therapy research project can directly refe..

Recently, T&L Biotechnology Ltd. (hereinafter referred to as "T&L") received a confirmation letter from the US Food and Drug Administration (hereinafter referred to as "FDA"), stating that the company's key raw materials for cell therapy drugs, CD3 m..